FDA Inspection 1294996 — Chongqing Sintaho Pharmaceuticals Co., Ltd.
The FDA completed an inspection of Chongqing Sintaho Pharmaceuticals Co., Ltd. on Oct 31, 2025 in Chongqing. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Oct 31, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Chongqing (China)